Alexandria Real Estate Equities
ARE
#2382
Rank
โ‚ฌ6.93 B
Marketcap
40,31ย โ‚ฌ
Share price
-1.05%
Change (1 day)
-38.02%
Change (1 year)
Alexandria Real Estate Equities, Inc. is a real estate investment trust that invests in office buildings and laboratories.

EPS for Alexandria Real Estate Equities (ARE)

EPS in 2026 (TTM): -5,14ย โ‚ฌ

According to Alexandria Real Estate Equities 's latest financial reports the company's current EPS (TTM) is -5,41ย โ‚ฌ. In 2025 the company made an earnings per share (EPS) of -7,54ย โ‚ฌ.

EPS history for Alexandria Real Estate Equities from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-5,14ย โ‚ฌ-31.78%
2025-7,54ย โ‚ฌ
20222,80ย โ‚ฌ-17.41%
20213,39ย โ‚ฌ-35.32%
20205,23ย โ‚ฌ89.03%
20192,77ย โ‚ฌ-12.68%
20183,17ย โ‚ฌ
20140,90ย โ‚ฌ-36.87%
20131,43ย โ‚ฌ46.79%
20120,97ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
0,68ย โ‚ฌ-112.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
26,70ย โ‚ฌ-593.13%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
14,49ย โ‚ฌ-367.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
-2,32ย โ‚ฌ-57.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
4,83ย โ‚ฌ-189.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
4,06ย โ‚ฌ-174.92%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
4,94ย โ‚ฌ-191.25%๐Ÿ‡บ๐Ÿ‡ธ USA